On this episode, Tom is having a chat with Lilac Mandeles, the Co-Founder and CEO of TechforCann. This European, Malta-based company identifies and accelerates IP and tech start-ups in the medical cannabis industry. Lilac talks about her move from the pharmaceutical sector, where she worked for the big players like Johnson & Johnson, Eli Lilly and Teva Pharmaceuticals, to the medical cannabis industry. 

She also shares her thoughts on the current state of innovation within the medical cannabis industry in Europe and the growth potential within it. Lilac also explains what the accelerator programme is and what early-stage start-ups can gain from joining it. And there is plenty to gain - from the necessary administrative and business development support to a significant grant and guidance through the first funding rounds. TechforCann is looking for new and promising medical cannabis start-ups, and admissions are now open. Is your start-up the right fit? Listen to the episode and find out what you can do to join this exciting and potentially life-changing program!

Other topics discussed:

• Lilac’s meeting with professor Raphael Mechoulammove - the first chemist to discover THC.
• Who is the team behind TechforCann?
• What is the difference between an incubator and an accelerator?
• How long does an accelerator program last?
• How to qualify for TechforCann?
• Are there any funds for innovative cannabis companies available in Malta?
• What is Malta Enterprise?
• How much funding does TechforCann offer?
• What support does TechforCann provide to the start-ups that get accepted?
• Is Europe going to legalise cannabis in the next 5 years?
• How can investors get involved? 

Links:

Smells Like Business - www.smellslikebusiness.com

TechforCann - www.techforcanneurope.com

LinkedIn - www.linkedin.com/company/techforcanneurope/